We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+35.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.9M
AUM Growth
+$16.2M
Cap. Flow
+$13.7M
Cap. Flow %
14.05%
Top 10 Hldgs %
51.86%
Holding
86
New
16
Increased
49
Reduced
9
Closed
4

Top Buys

Rank Stock Value
1
CS
Credit Suisse Group
CS
+$1.79M
2
NS
NuStar Energy L.P.
NS
+$1.64M
3
BCS icon
Barclays
BCS
+$1.41M
4
MLPA icon
Global X MLP ETF
MLPA
+$988K
5
EXPE icon
Expedia Group
EXPE
+$960K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$408K
2
IMGN
Immunogen Inc
IMGN
+$357K
3
CMG icon
Chipotle Mexican Grill
CMG
+$273K
4
SRPT icon
Sarepta Therapeutics
SRPT
+$265K
5
PPLI
People Inc
PPLI
+$249K

Sector Composition

Rank Sector Weight
1 Healthcare 24.97%
2 Consumer Discretionary 11.02%
3 Financials 10.96%
4 Communication Services 6.9%
5 Energy 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBYI icon
51
Puma Biotechnology
PBYI
$454M
$450K 0.46%
4,555
+472
+12% +$52.8K
NBL
52
DELISTED
Noble Energy, Inc.
NBL
$435K 0.44%
14,940
+540
+4% +$14.8K
INCY icon
53
Incyte
INCY
$24.4B
$431K 0.44%
+4,555
New +$476K
PXD
54
DELISTED
Pioneer Natural Resource Co.
PXD
$430K 0.44%
2,490
+90
+4% +$13.9K
PE
55
DELISTED
PARSLEY ENERGY INC
PE
$406K 0.41%
13,799
+499
+4% +$13.3K
LJPC
56
DELISTED
La Jolla Pharmaceutical Company
LJPC
$395K 0.4%
12,263
+1,271
+12% +$41.5K
GM.WS.B
57
DELISTED
General Motors Company
GM.WS.B
$393K 0.4%
16,814
– –
WFT
58
DELISTED
Weatherford International plc
WFT
$389K 0.4%
+93,375
New +$344K
ARRY
59
DELISTED
Array Biopharma Inc
ARRY
$376K 0.38%
29,367
+17,681
+151% +$201K
APA icon
60
APA Corp
APA
$13.2B
$372K 0.38%
8,819
+319
+4% +$13.4K
GDXJ icon
61
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
$371K 0.38%
10,864
+864
+9% +$28.2K
EIGI
62
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$327K 0.33%
38,961
+1,114
+3% +$9.42K
ICPT
63
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$304K 0.31%
5,204
-3,462
-40% -$218K
BTU icon
64
Peabody Energy
BTU
$2.9B
$302K 0.31%
7,678
+310
+4% +$10.1K
RARE icon
65
Ultragenyx Pharmaceutical
RARE
$2.55B
$302K 0.31%
6,508
-2,239
-26% -$110K
BMRN icon
66
BioMarin Pharmaceuticals
BMRN
$12.4B
$290K 0.3%
+3,254
New +$283K
DHC
67
Diversified Healthcare Trust
DHC
$2.14B
$285K 0.29%
14,877
– –
BIVV
68
DELISTED
Bioverativ Inc. Common Stock
BIVV
$280K 0.29%
5,201
+538
+12% +$29.4K
UA icon
69
Under Armour Class C
UA
$2.53B
$278K 0.28%
20,885
+885
+4% +$11.6K
CCS icon
70
Century Communities
CCS
$2.03B
$233K 0.24%
+7,485
New +$214K
NBIS
71
Nebius Group N.V.
NBIS
$47.7B
$219K 0.22%
6,693
– –
VWTR
72
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$172K 0.18%
13,462
+266
+2% +$4.25K
ESI icon
73
Element Solutions
ESI
$9.23B
$130K 0.13%
+13,116
New +$136K
GTE icon
74
Gran Tierra Energy
GTE
$317M
$129K 0.13%
4,789
+195
+4% +$4.36K
SAN icon
75
Banco Santander
SAN
$210B
$103K 0.11%
16,458
+806
+5% +$5.09K
1 2
3
4

Similar funds

MRP
Measured Risk Portfolios San Diego, California $91.4M AUM 0.88% 1-Year Est. Return
ITG
Index Technologies Group New York $91.8M AUM
MA
Marquette Associates Chicago, Illinois $91.9M AUM 13.47% 1-Year Est. Return
AW
Aspirean Wealth Mill Valley, California $92.1M AUM
SPCM
Spruce Point Capital Management New York $90.9M AUM
ML
MLP3 LLC Linwood, New Jersey $90.7M AUM
ICM
Incision Capital Management San Francisco, California $90.6M AUM
ACMC
Anchor Capital Management Company Raleigh, North Carolina $92.7M AUM 19.36% 1-Year Est. Return

Kazazian Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Kazazian Asset Management held 86 positions worth $97.9M, up 20% from $81.7M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Kazazian Asset Management deployed $13.7M of net new capital in Q4 2017, opening 16 new positions and adding to 49 existing holdings. Its largest new stake was Credit Suisse Group: 108,000 shares worth $1.93M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Biogen, an estimated $408K trimmed.

  • Kazazian Asset Management's largest Q4 2017 buy was Credit Suisse Group: 108,000 shares worth $1.93M.
  • Kazazian Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $846K increase.
  • Kazazian Asset Management's biggest Q4 2017 reduction was Biogen, cutting an estimated $408K.
  • Kazazian Asset Management fully exited Immunogen Inc in Q4 2017, selling an estimated $357K.
  • Kazazian Asset Management's ten largest holdings make up 52% of its $97.9M portfolio in Q4 2017.
  • Kazazian Asset Management opened 16 new positions and closed 4 in Q4 2017.
  • Kazazian Asset Management's portfolio value rose 20% quarter-over-quarter to $97.9M.

Based on Kazazian Asset Management's 13F filing for Q4 2017, filed 15 Feb 2018.